US 9220706
Inhibition of leukemic stem cells by PP2A activating agents
granted A61KA61K31/137A61K31/353
Quick answer
US patent 9220706 (Inhibition of leukemic stem cells by PP2A activating agents) held by THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
- Grant date
- Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/137, A61K31/353